<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00441051</url>
  </required_header>
  <id_info>
    <org_study_id>FESB-DE-310</org_study_id>
    <nct_id>NCT00441051</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Diclofenac Sodium (0.1%) Gel in Patients With UV Induced Painful Sunburn</brief_title>
  <official_title>A Randomized, Double-Blind, Vehicle-Controlled, Single Center, Intra-Individual Comparative Study of the Efficacy and Safety of Diclofenac Sodium 1 mg/g (0.1%) Gel in Subjects With Painful UV-Induced Erythema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diclofenac sodium 0.1% will be applied to sunburned skin when the intensity of pain reaches a
      certain level in order to evaluate the efficacy and safety of the treatment on this induced
      pain.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date>December 2006</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assess by Visual Analogue Scale (VAS)how products relieve provoked pain (by gloved finger)associated with sunburn in the first 24 hours after UV irradiation.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess the spontaneous pain and provoked pain by VAS , the reduction of erythema by erythema scale and chromametry and the safety by reporting adverse event.</measure>
  </secondary_outcome>
  <enrollment>45</enrollment>
  <condition>Sunburn</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac sodium 1mg/g</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have no skin problem which could interfere with the study results or increase the risk
             of adverse events Have no exposure to excessive or chronic UV radiation (i.e.,
             sunbathing, tanning salon use, phototherapy) within four weeks prior to inclusion, or
             planned during the study period Have non tanned skin on the areas to be exposed (back)
             Have a normal tolerance to UV and sun.

        Exclusion Criteria:

          -  Women who are pregnant, planning pregnancy or lactating A known hypersensitivity to
             diclofenac, aspirin, ibuprofen or other NSAIDs; Use of oral or topical treatments
             during the month preceding the trial, which may interfere with the results of the
             trial Other protocol-defined inclusion/exclusion criteria may appl
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine Queille- Roussel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de Pharmacologie Clinique Applique a la Dermatologie</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CPCAD</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2007</study_first_submitted>
  <study_first_submitted_qc>February 27, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 28, 2007</study_first_posted>
  <last_update_submitted>February 27, 2007</last_update_submitted>
  <last_update_submitted_qc>February 27, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 28, 2007</last_update_posted>
  <keyword>Sunburn, diclofenac, topical NSAID</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sunburn</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

